The effect of age on the magnitude and longevity of Th1-directed CD4 T-cell responses to SARS-CoV-2.


Journal

Immunology
ISSN: 1365-2567
Titre abrégé: Immunology
Pays: England
ID NLM: 0374672

Informations de publication

Date de publication:
07 2022
Historique:
revised: 09 03 2022
received: 17 01 2022
accepted: 19 03 2022
pubmed: 10 4 2022
medline: 24 6 2022
entrez: 9 4 2022
Statut: ppublish

Résumé

Age is associated with changes in the immune system which increase the risk for severe COVID-19. Here, we investigate SARS-CoV-2-reactive CD4 T cells from individuals recovered from SARS-CoV-2 infection with mild COVID-19 symptoms after 3, 6 and 9 months using incubation with SARS-CoV-2 S1, S2 and N-peptide pools, followed by flow cytometry for a Th1-activation profile or proliferation analyses. We found that SARS-CoV-2-reactive CD4 T cells are decreasing on average after 9 months but highly polyfunctional CD4 T cells can peak after 6-month recovery. We show that individuals older than 60 years of age have significantly more SARS-CoV-2-reactive T cells in their blood after 3 months of recovery compared to younger individuals and that the percentage of SARS-CoV-2-reactive Th1-directed CD4 T cells in the blood of mild-COVID-19-recovered individuals correlates with age. Finally, we show that individuals over the age of 40 have significantly increased the amounts of highly polyfunctional SARS-CoV-2-S-peptide-reactive CD4 T cells, compared to SARS-CoV-2 naïve individuals, than those under the age of 40. These findings suggest that in individuals recovered from mild COVID-19, increased age is associated with significantly more highly polyfunctional SARS-CoV-2-reactive CD4 T cells with a Th1-profile and that these responses persist over time.

Identifiants

pubmed: 35396852
doi: 10.1111/imm.13475
pmc: PMC9111694
doi:

Substances chimiques

Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

327-340

Informations de copyright

© 2022 The Authors. Immunology published by John Wiley & Sons Ltd.

Références

Nature. 2020 Aug;584(7821):457-462
pubmed: 32668444
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Curr Opin HIV AIDS. 2011 May;6(3):174-80
pubmed: 21502921
J Virol. 2011 Oct;85(20):10464-71
pubmed: 21813600
Proc Natl Acad Sci U S A. 2005 May 17;102(20):7239-44
pubmed: 15872023
Front Immunol. 2018 Jan 10;8:1960
pubmed: 29375577
Immunity. 2020 Dec 15;53(6):1258-1271.e5
pubmed: 33296686
Nat Commun. 2020 Nov 17;11(1):5829
pubmed: 33203887
Natl Sci Rev. 2020 Jun;7(6):998-1002
pubmed: 34676125
Blood. 2006 Jun 15;107(12):4781-9
pubmed: 16467198
J Immunol. 2020 Oct 15;205(8):1990-1997
pubmed: 32826281
Med (N Y). 2021 Mar 12;2(3):281-295.e4
pubmed: 33589885
J Virol. 2010 Sep;84(18):9318-25
pubmed: 20610717
Nature. 2022 Jan;601(7891):110-117
pubmed: 34758478
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941
Nat Commun. 2021 Jul 29;12(1):4678
pubmed: 34326343
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Lancet Respir Med. 2020 Sep;8(9):e70
pubmed: 32771081
Arch Virol. 2009;154(7):1093-9
pubmed: 19526193
Cell. 2020 Nov 12;183(4):996-1012.e19
pubmed: 33010815
J Immunol. 2021 Aug 15;207(4):1099-1111
pubmed: 34312258
Cell Rep. 2021 Feb 9;34(6):108728
pubmed: 33516277
Nat Rev Immunol. 2020 Sep;20(9):529-536
pubmed: 32728222
Immunity. 2016 Jun 21;44(6):1379-91
pubmed: 27287409
Nat Commun. 2021 Jun 30;12(1):4043
pubmed: 34193870
J Infect Dis. 2021 Jul 15;224(2):241-245
pubmed: 33961690
Nat Immunol. 2021 May;22(5):620-626
pubmed: 33674800
Nat Immunol. 2021 Jan;22(1):32-40
pubmed: 33277638
Semin Immunol. 2012 Oct;24(5):365-72
pubmed: 22560928
Annu Rev Immunol. 2019 Apr 26;37:521-546
pubmed: 30726153
Curr Opin HIV AIDS. 2013 Jul;8(4):333-40
pubmed: 23743723
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
JCI Insight. 2021 Aug 9;6(15):
pubmed: 34143754
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Aging Cell. 2016 Feb;15(1):14-21
pubmed: 26472076
Nat Commun. 2021 Feb 19;12(1):1162
pubmed: 33608522
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
Immunology. 2022 Jul;166(3):327-340
pubmed: 35396852
BMJ. 2020 May 22;369:m1985
pubmed: 32444460

Auteurs

Ryan G Nattrass (RG)

Institute of Virology, University Hospital Bonn, Bonn, Germany.
German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Braunschweig, Germany.

Lisa Krafft (L)

Institute of Virology, University Hospital Bonn, Bonn, Germany.
German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Braunschweig, Germany.

Polina Zjablovskaja (P)

Miltenyi Biotec, Bergisch Gladbach, Germany.

Marc Schuster (M)

Miltenyi Biotec, Bergisch Gladbach, Germany.

Bahram Kasmapour (B)

Miltenyi Biotec, Bergisch Gladbach, Germany.

Cem Sarisoy (C)

Institute of Virology, University Hospital Bonn, Bonn, Germany.
German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Braunschweig, Germany.

Jessica Minich (J)

Institute of Virology, University Hospital Bonn, Bonn, Germany.
German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Braunschweig, Germany.

Elena Bach (E)

Institute of Virology, University Hospital Bonn, Bonn, Germany.
German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Braunschweig, Germany.

Hendrik Streeck (H)

Institute of Virology, University Hospital Bonn, Bonn, Germany.
German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Braunschweig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH